Clinical trials
Terminated Observational Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 2 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Corporacion Parc Tauli | 1 |
| CureOne | 1 |
| Duke University | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Ferring Pharmaceuticals | 1 |
| Hopital Foch | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Mayo Clinic | 1 |
| Medical Diagnostic Laboratories, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 18 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colonic Neoplasms | 2 |
| Kidney Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.